Intensive chemotherapy with combinations containing anthracyclines for refractory and relapsing multiple myeloma
Open Access
- 1 February 1990
- journal article
- Published by Wiley in European Journal of Haematology
- Vol. 44 (2) , 121-124
- https://doi.org/10.1111/j.1600-0609.1990.tb00362.x
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Plasma cell myeloma--new biological insights and advances in therapyBlood, 1989
- VAD chemotherapy for refractory multiple myelomaBritish Journal of Haematology, 1989
- Potential value of vintristine‐adriamycin‐dexamethasone combination chemotherapy (VAD) in refractory and rapidly progressive myelomaEuropean Journal of Haematology, 1987
- Treatment of multiple myeloma with an intensive 5‐drug combination or intermittent melphalan and prednisone; a randomised multicentre trialEuropean Journal of Haematology, 1987
- The efficacy and toxicity of VAD in the treatment of myeloma and related disordersScandinavian Journal of Haematology, 1986
- High-Dose Glucocorticoid Treatment of Resistant MyelomaAnnals of Internal Medicine, 1986
- COMBINATION CHEMOTHERAPY WITH VINCKISTINE, DOXORUBICIN, DEXAMETHASONE FOR REFRACTORY OR KELAPSING MULTIPLE MYELOMABritish Journal of Haematology, 1986
- Aggressive combination chemotherapy in multiple myeloma. A multicentre trialScandinavian Journal of Haematology, 1985
- Effective Treatment of Advanced Multiple Myeloma Refractory to Alkylating AgentsNew England Journal of Medicine, 1984
- Prednisone pulse therapy for refractory myelomaBlood, 1983